Literature DB >> 28730674

Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma.

Spyridon Gkalpakiotis1, Petr Arenberger1, Marketa Fridman1, Monika Arenbergerova1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28730674     DOI: 10.1111/dth.12522

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


× No keyword cloud information.
  2 in total

1.  miR-498 Targets UBE2T to Inhibit the Proliferation of Malignant Melanoma Cells.

Authors:  Wen Cao; Li Ni; Pin Li; Qi-Xia Wang; Ming-Ming Li; Shu-Hong Huang; Ning-Ning Dang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 2.  Risk of Developing Melanoma With Systemic Agents Used to Treat Psoriasis: A Review of the Literature.

Authors:  Amy Semaka; Thomas G Salopek
Journal:  J Cutan Med Surg       Date:  2021-08-15       Impact factor: 2.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.